Developer docs
API playgroundTry for free, no card

Search company profiles

Star Laboratories

Full company profile

uuid02m8ott

Namestring
Star Laboratories
Legal namestring
Star Laboratories Pvt Ltd.
Websiteurl
starlabs.com.pk
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Star Laboratories is a Pakistan-based pharmaceutical manufacturer founded in 1960 in Lahore by Muhammad Iqbal Malik and now operated under family ownership across three generations of the Malik family. The company manufactures generic medicines across two business units: human healthcare (antibiotics, anti-malarials, vitamins, anti-inflammatory, CNS, GI, and dermatology products) and veterinary healthcare (antibiotics, anti-parasitics, reproductive hormones, vitamins, and nutritionals for livestock, poultry, and pets). The portfolio exceeds 500 SKUs spanning injectables, oral solids, oral liquids, topicals, semi-solids, and aerosols, manufactured at a single integrated facility on Multan Road in Lahore.

The company operates a B2B enterprise field sales model, selling through international distributors across 30+ countries spanning the Middle East and North Africa, Sub-Saharan Africa, South Asia, Central Asia, and Southeast Asia, alongside domestic Pakistani sales. Manufacturing infrastructure uses modular production systems with automation and real-time data analytics, certified to ISO 9001:2015 (since 2018), ISO 14001:2015, and ISO 45001:2018. A dedicated R&D division established in 1999 supports formulation development, with stated but unsubstantiated use of genomics, biotechnology, and artificial intelligence in drug discovery. Pricing is quote-based for bulk orders, consistent with traditional generic pharmaceutical distribution norms, and no revenue, headcount, or financial details are publicly disclosed.

The go-to-market relies on distributor relationships, international trade exhibitions (Angola FILDA, Kenya Aviana Vet, Philippines Livestock Expo), customer delegation exchanges, and PR-driven earned media rather than digital channels. The company has been recognized with consecutive PESA Export Awards from PPMA as Pakistan's top pharmaceutical exporter in 2023 and 2024. Star Laboratories remains a privately held company with no institutional funding rounds, no acquisition activity, and no parent company, distinguishing it from publicly listed Pakistani pharma peers and positioning it as a founder-led, export-driven mid-tier generic manufacturer.

Short descriptiontext

Star Laboratories is a Lahore-based pharmaceutical manufacturer producing 500+ generic medicines for human and veterinary healthcare, exporting to 30+ countries across MENA, Sub-Saharan Africa, Central Asia, South Asia, and Southeast Asia through B2B distributor networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLahore, Pakistan
HQ citystring
Lahore
HQ countrystring
Pakistan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, veterinary medicines, human generic drugs, antibiotic formulations, pharmaceutical exports
Industry4 codes
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAE
Antimicrobials & Anti-infectives
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAD
Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Manufacturing and selling pharmaceutical products for both human and veterinary healthcare. Revenue generated through domestic sales and international exports of medications including injectables, oral solids, liquid dosage forms, and topical treatments.

starlabs.com.pk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Star Laboratories manufactures and sells a portfolio of 500+ generic pharmaceutical formulations for human and veterinary healthcare, including oral solids (tablets, capsules, suspensions), injectables, oral liquids, topical treatments, boluses, powders, drenches, and aerosol sprays. The company produces antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics, anti-inflammatories, anti-malarials, vitamins and supplements, and gastrointestinal medications, selling to distributors, hospitals, pharmacies, veterinarians, doctors, and agricultural businesses across 30+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Products trusted in over 30 countries globally
+2 more records
Product overview1 text field

Star Laboratories is a pharmaceutical company with over 60 years of experience, offering a diverse portfolio of more than 500 pharmaceutical products for both human and animal healthcare. The company operates in two main divisions: Human Pharmaceuticals and Veterinary Medicines. Human products include oral solids (tablets, capsules, suspensions), injectable/parenteral formulations, oral liquids, and topical products. Veterinary products span injectables, liquid dosage forms, solid dosage forms (boluses, powders), semi-solid preparations, and aerosol/spray formulations. The portfolio includes antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics (albendazole, levamisole, ivermectin), anti-inflammatories, vitamins and supplements, anti-malarials, and gastrointestinal medications. The company serves global markets across Middle East, Africa, South Asia, Central Asia, and Southeast Asia, exporting to over 30 countries.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pakistan-based pharmaceutical manufacturer producing generic and branded formulations across human therapeutic areas. Directly comparable as a fellow top-tier Pakistani pharma exporter with similar international ambitions and product breadth.

TypeDirect peer
Description

Pakistani pharma company with diversified portfolio including human generics and healthcare products. Comparable scale and export orientation, listed on the Pakistan Stock Exchange providing market reference for valuation.

TypeDirect peer
Description

Pakistani pharmaceutical manufacturer producing a broad range of branded generics for human health. Closely comparable in terms of product mix (antibiotics, anti-malarials, NSAIDs) and domestic plus export orientation.

4Nabiqasim Industries
TypeDirect peer
Description

Pakistan-based pharmaceutical manufacturer offering infusions, injectables, and oral formulations across therapeutic categories. Directly comparable in dosage-form breadth and B2B pharma distribution model.

TypeDirect peer
Description

Pakistani pharmaceutical manufacturer with significant export presence across multiple continents. Comparable in scale, manufacturing capabilities, and emerging-market export footprint similar to Star Labs.

TypeDirect peer
Description

Pakistani pharmaceutical company focused on branded generics with international distribution. Comparable in product portfolio and export-driven business model serving emerging markets.

TypeDirect peer
Description

Pakistani pharma manufacturer with broad branded-generic portfolio including human and consumer health products. Comparable in scale, manufacturing maturity, and therapeutic area coverage.

TypeBroad incumbent
Description

India-based global generic pharmaceutical manufacturer with extensive API and finished dosage portfolio across 150+ countries. Comparable as a much larger established exporter in many of the same therapeutic categories and emerging markets where Star Labs competes.

TypeBroad incumbent
Description

One of India's largest pharmaceutical companies with strong presence in Africa, South Asia, and emerging markets, including notable leadership in anti-malarials and respiratory products. Directly competes in Star Labs' core therapeutic and geographic segments.

TypeRegional player
Description

South Africa-headquartered global specialty and generics pharmaceutical company with strong African distribution footprint. Comparable as a large-scale emerging-market pharma manufacturer targeting similar institutional buyer segments across Sub-Saharan Africa.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Star Laboratories

Pharmaceutical Manufacturingstarlabs.com.pk

Star Laboratories is a Lahore-based pharmaceutical manufacturer producing 500+ generic medicines for human and veterinary healthcare, exporting to 30+ countries across MENA, Sub-Saharan Africa, Central Asia, South Asia, and Southeast Asia through B2B distributor networks.

What Star Laboratories does

Star Laboratories is a Pakistan-based pharmaceutical manufacturer founded in 1960 in Lahore by Muhammad Iqbal Malik and now operated under family ownership across three generations of the Malik family. The company manufactures generic medicines across two business units: human healthcare (antibiotics, anti-malarials, vitamins, anti-inflammatory, CNS, GI, and dermatology products) and veterinary healthcare (antibiotics, anti-parasitics, reproductive hormones, vitamins, and nutritionals for livestock, poultry, and pets). The portfolio exceeds 500 SKUs spanning injectables, oral solids, oral liquids, topicals, semi-solids, and aerosols, manufactured at a single integrated facility on Multan Road in Lahore.

The company operates a B2B enterprise field sales model, selling through international distributors across 30+ countries spanning the Middle East and North Africa, Sub-Saharan Africa, South Asia, Central Asia, and Southeast Asia, alongside domestic Pakistani sales. Manufacturing infrastructure uses modular production systems with automation and real-time data analytics, certified to ISO 9001:2015 (since 2018), ISO 14001:2015, and ISO 45001:2018. A dedicated R&D division established in 1999 supports formulation development, with stated but unsubstantiated use of genomics, biotechnology, and artificial intelligence in drug discovery. Pricing is quote-based for bulk orders, consistent with traditional generic pharmaceutical distribution norms, and no revenue, headcount, or financial details are publicly disclosed.

The go-to-market relies on distributor relationships, international trade exhibitions (Angola FILDA, Kenya Aviana Vet, Philippines Livestock Expo), customer delegation exchanges, and PR-driven earned media rather than digital channels. The company has been recognized with consecutive PESA Export Awards from PPMA as Pakistan's top pharmaceutical exporter in 2023 and 2024. Star Laboratories remains a privately held company with no institutional funding rounds, no acquisition activity, and no parent company, distinguishing it from publicly listed Pakistani pharma peers and positioning it as a founder-led, export-driven mid-tier generic manufacturer.

Star Laboratories firmographics

Firmographics
Name
Star Laboratories
Legal name
Star Laboratories Pvt Ltd.
Website
https://starlabs.com.pk
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
51–100 employees
Short description
Star Laboratories is a Lahore-based pharmaceutical manufacturer producing 500+ generic medicines for human and veterinary healthcare, exporting to 30+ countries across MENA, Sub-Saharan Africa, Central Asia, South Asia, and Southeast Asia through B2B distributor networks.
Ownership category
akta.pro rank

Star Laboratories industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAE
Antimicrobials & Anti-infectives
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAD
Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAIABAL
Generic Hospital & Institutional Products

Keywords

  • Pharmaceutical manufacturing
  • Veterinary medicines
  • Human generic drugs
  • Antibiotic formulations
  • Pharmaceutical exports

Where Star Laboratories is headquartered

Location

Headquarters

HQ city
Lahore
HQ country
Pakistan
HQ region
Asia

Offices1 record

Markets served

Star Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Manufacturing and selling pharmaceutical products for both human and veterinary healthcare. Revenue generated through domestic sales and international exports of medications including injectables, oral solids, liquid dosage forms, and topical treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Star Laboratories product offering

Product offering

Core offering

Star Laboratories manufactures and sells a portfolio of 500+ generic pharmaceutical formulations for human and veterinary healthcare, including oral solids (tablets, capsules, suspensions), injectables, oral liquids, topical treatments, boluses, powders, drenches, and aerosol sprays. The company produces antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics, anti-inflammatories, anti-malarials, vitamins and supplements, and gastrointestinal medications, selling to distributors, hospitals, pharmacies, veterinarians, doctors, and agricultural businesses across 30+ countries.

Product overview

Star Laboratories is a pharmaceutical company with over 60 years of experience, offering a diverse portfolio of more than 500 pharmaceutical products for both human and animal healthcare. The company operates in two main divisions: Human Pharmaceuticals and Veterinary Medicines. Human products include oral solids (tablets, capsules, suspensions), injectable/parenteral formulations, oral liquids, and topical products. Veterinary products span injectables, liquid dosage forms, solid dosage forms (boluses, powders), semi-solid preparations, and aerosol/spray formulations. The portfolio includes antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics (albendazole, levamisole, ivermectin), anti-inflammatories, vitamins and supplements, anti-malarials, and gastrointestinal medications. The company serves global markets across Middle East, Africa, South Asia, Central Asia, and Southeast Asia, exporting to over 30 countries.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Products trusted in over 30 countries globally
  • +2 more outcomes

Companies that use Star Laboratories

Customer profile

Segments2 records

Ideal customer profiles2 records

Star Laboratories technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Star Laboratories partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves10 records

Expansion highlights5 records

Star Laboratories competitors and assessment

Company assessment

Direct peers

  • Getz Pharma: Pakistan-based pharmaceutical manufacturer producing generic and branded formulations across human therapeutic areas. Directly comparable as a fellow top-tier Pakistani pharma exporter with similar international ambitions and product breadth.
  • Ferozsons Laboratories: Pakistani pharma company with diversified portfolio including human generics and healthcare products. Comparable scale and export orientation, listed on the Pakistan Stock Exchange providing market reference for valuation.
  • Hilton Pharma: Pakistani pharmaceutical manufacturer producing a broad range of branded generics for human health. Closely comparable in terms of product mix (antibiotics, anti-malarials, NSAIDs) and domestic plus export orientation.
  • Nabiqasim Industries: Pakistan-based pharmaceutical manufacturer offering infusions, injectables, and oral formulations across therapeutic categories. Directly comparable in dosage-form breadth and B2B pharma distribution model.
  • AGP Limited: Pakistani pharmaceutical manufacturer with significant export presence across multiple continents. Comparable in scale, manufacturing capabilities, and emerging-market export footprint similar to Star Labs.
  • Bosch Pharmaceuticals: Pakistani pharmaceutical company focused on branded generics with international distribution. Comparable in product portfolio and export-driven business model serving emerging markets.
  • Searle Pakistan: Pakistani pharma manufacturer with broad branded-generic portfolio including human and consumer health products. Comparable in scale, manufacturing maturity, and therapeutic area coverage.

Broad incumbents

  • Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with extensive API and finished dosage portfolio across 150+ countries. Comparable as a much larger established exporter in many of the same therapeutic categories and emerging markets where Star Labs competes.
  • Cipla: One of India's largest pharmaceutical companies with strong presence in Africa, South Asia, and emerging markets, including notable leadership in anti-malarials and respiratory products. Directly competes in Star Labs' core therapeutic and geographic segments.

Regional players

  • Aspen Pharmacare: South Africa-headquartered global specialty and generics pharmaceutical company with strong African distribution footprint. Comparable as a large-scale emerging-market pharma manufacturer targeting similar institutional buyer segments across Sub-Saharan Africa.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Star Laboratories compliance and trust

Trust signal

Compliance3 records

Star Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Star Laboratories leadership team

Management profile

Number of profiles

Profiles8 records

Star Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Star Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Star Laboratories

What does Star Laboratories do?

Star Laboratories manufactures and sells a portfolio of 500+ generic pharmaceutical formulations for human and veterinary healthcare, including oral solids (tablets, capsules, suspensions), injectables, oral liquids, topical treatments, boluses, powders, drenches, and aerosol sprays. The company produces antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics, anti-inflammatories, anti-malarials, vitamins and supplements, and gastrointestinal medications, selling to distributors, hospitals, pharmacies, veterinarians, doctors, and agricultural businesses across 30+ countries.

Is Star Laboratories a public or private company?

Star Laboratories is a private company. It is classified as family owned and is currently operating.

When was Star Laboratories founded?

Star Laboratories was founded in 1960. It employs 51 to 100 people.

Where is Star Laboratories based?

Star Laboratories is headquartered in Lahore, Pakistan, in the Asia region.

How does Star Laboratories make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Star Laboratories's main competitors?

Direct peers on record are Getz Pharma, Ferozsons Laboratories, Hilton Pharma, Nabiqasim Industries, AGP Limited, Bosch Pharmaceuticals and Searle Pakistan. Broad incumbents are Aurobindo Pharma and Cipla. Aspen Pharmacare is listed as a regional player.

Does Star Laboratories have an API?

No public API is recorded for Star Laboratories.

What industry is Star Laboratories in?

Star Laboratories's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals, with a secondary code of HLAMAEAE, Antimicrobials & Anti-infectives. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales